Some IBD Patients Have Increased Skin Cancer Risk

Past research has cautioned about the risk of skin cancer with use of immunosuppressive medications. Yet, a new study pointed out, there is limited information on repeated basal cell cancer (BCC) occurrences among inflammatory bowel disease (IBD) patients, especially those who use immunosuppressive medications.

VA Primary Care Not Following SSTI Guidelines Enough

SALT LAKE CITY — Guidelines aren’t followed enough when skin and soft tissue infections are managed in the outpatient setting outside of emergency departments, a new study pointed out. The article in Clinical Infectious Diseases noted the lack of data on treatment...

Teledermoscopy Enhances Remote Dermatology Consults

PORTSMOUTH, VA—Use of teledermatology has increased at military treatment facilities in response to greater demand for dermatologic care throughout military medicine and persistent, dermatologic provider shortages, according to a new study. The article in Military...

IBD Treatment Can Increase Squamous Cell Cancer Risk

PHILADELPHIA—Treatment with thiopurines is associated with an increased risk of squamous cell carcinoma of the skin in patients with inflammatory bowel diseases, according to a new study. Researchers from the Corporal Michel J. Crescenz VAMC and the University of...

High Satisfaction with Teledermatology at Atlanta VAMC

ATLANTA—Teledermatology is comparable to face-to-face visits in providing accurate diagnoses and effective treatments, but it is not clear how patients feel about teledermatology models that more directly convey provider recommendations to patients. A study in the...

Erectile Dysfunction Drugs and Skin Cancer in Veterans

LEXINGTON, KY—Is there a relationship between phosphodiesterase 5 inhibitor drugs, prescribed for erectile dysfunction, and skin cancers? A large-scale study of veterans sought to determine that. A retrospective review using the VAs Informatics and Computing...